iii

Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s diseaseRoche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease

Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…

6 days ago
Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodons Board of DirectorsAccomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodons Board of Directors

Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodons Board of Directors

CROWN POINT, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Neurodon Corp., a leader in the development of endoplasmic reticulum (ER)…

1 week ago

Hyundai Motor Group Opens ZER01NE Fund III to Drive Future Technology Innovation with Startups

ZER01NE Fund III, valued at KRW 125 billion, aims to accelerate innovation in future technologies through early-stage startup investmentsThe fund…

2 weeks ago
Energize Capital raises $430 million to capitalize and scale digitally-enabled climate solutionsEnergize Capital raises $430 million to capitalize and scale digitally-enabled climate solutions

Energize Capital raises $430 million to capitalize and scale digitally-enabled climate solutions

Backed by leading institutional Limited Partners, Ventures Fund III underscores the need for thematically aligned investors in today's market CHICAGO,…

2 weeks ago